DINOTO, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 1.504
EU - Europa 1.495
AS - Asia 1.302
SA - Sud America 248
AF - Africa 81
Continente sconosciuto - Info sul continente non disponibili 66
Totale 4.696
Nazione #
US - Stati Uniti d'America 1.435
RU - Federazione Russa 864
SG - Singapore 589
IT - Italia 262
CN - Cina 222
BR - Brasile 202
VN - Vietnam 153
HK - Hong Kong 123
GB - Regno Unito 76
DE - Germania 58
IE - Irlanda 47
BD - Bangladesh 45
CA - Canada 42
KR - Corea 37
FI - Finlandia 34
IN - India 32
FR - Francia 31
SE - Svezia 29
JP - Giappone 24
ZA - Sudafrica 22
AR - Argentina 20
NL - Olanda 18
TG - Togo 18
ID - Indonesia 16
BJ - Benin 15
PL - Polonia 15
MX - Messico 13
IQ - Iraq 12
AT - Austria 10
PK - Pakistan 8
TR - Turchia 8
UA - Ucraina 8
ES - Italia 7
NG - Nigeria 7
MA - Marocco 6
BE - Belgio 5
CL - Cile 5
EC - Ecuador 5
JM - Giamaica 5
LT - Lituania 5
PH - Filippine 5
CZ - Repubblica Ceca 4
PE - Perù 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
CH - Svizzera 3
EG - Egitto 3
LU - Lussemburgo 3
PY - Paraguay 3
TN - Tunisia 3
UZ - Uzbekistan 3
VE - Venezuela 3
CO - Colombia 2
CR - Costa Rica 2
KE - Kenya 2
LB - Libano 2
MD - Moldavia 2
NP - Nepal 2
OM - Oman 2
PT - Portogallo 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AL - Albania 1
AZ - Azerbaigian 1
BB - Barbados 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DZ - Algeria 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
HT - Haiti 1
HU - Ungheria 1
IL - Israele 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MK - Macedonia 1
ML - Mali 1
MY - Malesia 1
MZ - Mozambico 1
PR - Porto Rico 1
RO - Romania 1
SI - Slovenia 1
SN - Senegal 1
TW - Taiwan 1
Totale 4.630
Città #
Singapore 329
Moscow 319
Ashburn 285
San Jose 246
Hong Kong 120
Dallas 92
Chandler 77
Verona 63
Council Bluffs 60
Ho Chi Minh City 58
Los Angeles 55
Beijing 53
Dublin 43
New York 42
The Dalles 39
Hanoi 35
Milan 34
London 29
Munich 23
Santa Clara 23
São Paulo 23
Buffalo 22
Redondo Beach 19
Lomé 18
Tokyo 17
Montreal 16
Cotonou 15
Phoenix 15
Warsaw 15
Helsinki 14
Orem 14
Rome 14
Lappeenranta 13
Bologna 11
Johannesburg 11
Denver 10
Haiphong 10
Jakarta 10
Da Nang 9
Frankfurt am Main 9
Houston 9
Mexico City 9
Naples 9
Toronto 9
Chicago 8
Florence 8
Poplar 8
Abuja 7
Atlanta 7
Brooklyn 7
Washington 7
Amsterdam 6
Boston 6
Cape Town 6
Chennai 6
Guangzhou 6
Kent 6
Lawrence 6
Princeton 6
Seattle 6
Stockholm 6
Brasília 5
Brussels 5
Campinas 5
Fortaleza 5
Kolkata 5
Nuremberg 5
Rio de Janeiro 5
Seoul 5
Sindelfingen 5
Treviso 5
Baghdad 4
Belo Horizonte 4
Berlin 4
Bắc Ninh 4
Casablanca 4
City of London 4
Columbus 4
Figino 4
Mumbai 4
Palermo 4
Pescara 4
Philadelphia 4
Tianjin 4
Turku 4
Udine 4
Venice 4
Vienna 4
Xi'an 4
Bauru 3
Bexley 3
Biên Hòa 3
Boardman 3
Brescia 3
Delhi 3
Guayaquil 3
Hyderabad 3
Lahore 3
Las Vegas 3
Lima 3
Totale 2.613
Nome #
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management 251
Cognitive Profile in Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Comparative Study With Multiple Sclerosis 151
Autoimmune movement disorders complicating treatment with immune checkpoint inhibitors 149
Autoimmune encephalitis misdiagnosis and mimics 144
Is there a correlation between MOGAD and SARS-CoV-2 infection? 143
Investigating paraneoplastic aquaporin-4 positive neuromyelitis optica spectrum disorder through a data-driven approach 139
Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD 131
A novel cell-based immunofluorescence assay for the detection of autoantibodies to myelin-associated glycoprotein 131
Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum Disorder 129
Fatigue in Multiple Sclerosis: a resting-state EEG microstate study 127
Non-demyelinating disorders mimicking and misdiagnosed as NMOSD, a literature review 123
Cerebellar involvement associated with immune checkpoint inhibitors: a systematic review 122
SARS-CoV-2 antibodies in inflammatory neurological conditions: a multicentre retrospective comparative study 122
Clinical Characterization and Long-Term Outcome in Children and Adults With Anti-AMPA Receptor Encephalitis 120
Investigating the association between neoplasms and MOG antibody-associated disease 119
Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder 118
Neuronal intermediate filament paraneoplastic autoimmunity complicating avelumab therapy of Merkel cell carcinoma 115
Autoimmune dementia 113
Peripheral neuropathy and MOG-IgG: a clinical and neuropathological retrospective study 111
Clinical Course of Neurologic Adverse Events Associated With Immune Checkpoint Inhibitors: Focus on Chronic Toxicities 111
Safety profile of SARS-CoV-2 vaccination in patients with antibody-mediated CNS disorders 108
Neurologic sequelae of COVID-19 are determined by immunologic imprinting from previous coronaviruses 104
Complement activation profiles predict clinical outcomes in myelin oligodendrocyte glycoprotein antibody-associated disease 101
Neurofilament light chain: a promising diagnostic biomarker for functional motor disorders 101
Cerebellar Involvement in Attacks of Aquaporin-4-IgG Positive Neuromyelitis Optica Spectrum Disorder 100
Biomarkers for cognitive impairment in alpha-synucleinopathies: an overview of systematic reviews and meta-analyses 96
Serum and cerebrospinal fluid biomarkers in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein associated disease 96
Clinical Features and Factors Associated With Outcome in Late Adult-Onset Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease 95
HLA-DQB1*05 subtypes and not DRB1*10:01 mediates risk in anti-IgLON5 disease 95
Is there an immunological cross-reactivity of antibodies to the myelin oligodendrocyte glycoprotein and coronaviruses? 91
Prospectively assessing serum neurofilament light chain levels as a biomarker of paclitaxel-induced peripheral neurotoxicity in breast cancer patients 90
Cerebrospinal 14-3-3 Protein Levels as a Neuroaxonal Biomarker in Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder 89
Serum Levels of Neurofilament Light Chain and Glial Fibrillary Acidic Protein Correlate with Disease Severity in Patients with West Nile Virus Infection 89
Assessment of neuronal and glial serum biomarkers in myelin oligodendrocyte glycoprotein antibody-associated disease: the MULTIMOGAD study 82
Neutropenia complicating anti-CD20 treatment in patients with multiple sclerosis: A retrospective case series and a systematic review of reported cases 80
Diagnosing an unusual case of myelitis and diabetes insipidus through skin biopsies 80
More efficient complement activation by Anti-Aquaporin-4 compared with Anti-Myelin Oligodendrocyte Glycoprotein antibodies 78
Treatment options in refractory autoimmune encephalitis 77
Real-Life Evaluation of the MOGAD Diagnostic Criteria: Application Challenges and Discrepancies 75
Autoimmune and paraneoplastic disorders of the nervous system 66
Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease 64
Epstein-Barr virus infection in patients with MOGAD 51
Soluble TREM2 distinguishes neuromyelitis optica spectrum disorder from MOG antibody disease 50
Unveiling Disability Accrual Mechanisms in AQP4-IgG-Positive NMOSD 35
Validation of the MOG-AR Score: A Retrospective Multicenter Study 25
Neuroglial markers of damage in autoimmune neurology 7
Immuno-Proteomic Features Associated to Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease 2
Totale 4.696
Categoria #
all - tutte 18.168
article - articoli 17.960
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 208
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.336


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202231 0 0 0 0 0 0 0 0 2 13 9 7
2022/2023236 6 18 13 32 18 69 4 15 32 6 13 10
2023/2024294 12 15 23 30 21 48 14 25 12 14 56 24
2024/2025856 48 27 34 121 48 44 49 50 136 71 88 140
2025/20263.087 184 160 144 517 920 168 290 204 218 159 72 51
2026/2027192 68 123 1 0 0 0 0 0 0 0 0 0
Totale 4.696